Skip to main content
Clinical Trials/NCT01737749
NCT01737749
Unknown
N/A

Validation of Neurokeeper's Algorithm on Patients Undergoing Cardiac Surgery.

Neurokeeper Technologies1 site in 1 countryNovember 29, 2012
ConditionsStroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke
Sponsor
Neurokeeper Technologies
Locations
1
Primary Endpoint
Neurological detrioration detection
Last Updated
13 years ago

Overview

Brief Summary

The primary objective of the study is to check the ability of Neurokeeper's algorithm system to detect and monitor changes in cerebral electrophysiological parameters as compared to clinical evaluation in patients undergoing cardiac surgery.

The secondary objectives is correlations of EEG + ERP measurements with clinical evaluations as assessed by NIHSS ThiS study is a prospective, open label, single arm, self control, single center study.

This study will be conducted in 50 subjects according to the inclusions/exclusions criteria.

Registry
clinicaltrials.gov
Start Date
November 29, 2012
End Date
TBD
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Neurokeeper Technologies
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years old.
  • Patients undergoing cardiac surgery .

Exclusion Criteria

  • Previous major hemispheric stroke.
  • Any known major hemispheric lesion.
  • Significant movement disorder.
  • Local skull or skin affliction which prevents electrodes application.
  • Any known condition which in the opinion of the investigator may interfere with the protocol implementation.

Outcomes

Primary Outcomes

Neurological detrioration detection

The primary objective of the study is to validate an EEG base algorithm system to detect and monitor changes in cerebral electrophysiological parameters as compared to clinical evaluation in patients undergoing cardiac surgery.

Secondary Outcomes

  • Time from deterioration to detection

Study Sites (1)

Loading locations...

Similar Trials